Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.
AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.
Prosper Junior Bakiny has positions in Eli Lilly and Viking Therapeutics. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. Eli Lilly holds the lead position in ...
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...
Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, as the ...
The drugmaker posted revenue of $17.6 billion in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $16.01 billion. Lilly expects full-year earnings in the range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback